epirubicin has been researched along with Plasmodium vivax Malaria in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Almeida, LD; Andrade, CH; Baia-da-Silva, DC; Bargieri, DY; Bilsland, E; Calit, J; Cassiano, GC; Costa, FTM; Cravo, PVL; Ferreira, LT; Lacerda, MVG; Lima, MNDN; Lopes, SCP; Melo, GC; Mottin, M; Neves, BJ; Puça, MCSB; Rodrigues, J; Souza, MF; Sunnerhagen, P; Tavella, TA; Tomaz, KCP | 1 |
1 other study(ies) available for epirubicin and Plasmodium vivax Malaria
Article | Year |
---|---|
Computational Chemogenomics Drug Repositioning Strategy Enables the Discovery of Epirubicin as a New Repurposed Hit for Plasmodium falciparum and P. vivax.
Topics: Animals; Antimalarials; Drug Repositioning; Epirubicin; Malaria, Vivax; Mice; Plasmodium falciparum; Plasmodium vivax | 2020 |